[HTML][HTML] Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study
G Jonsdottir, SH Lund, M Björkholm, I Turesson… - …, 2016 - ncbi.nlm.nih.gov
Survival in multiple myeloma patients who develop second malignancies: a population-based
cohort study - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
cohort study - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
[引用][C] Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study
G Jonsdottir, SH Lund, M Björkholm, I Turesson… - …, 2016 - diva-portal.org
[HTML][HTML] Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study
G Jonsdottir, SH Lund, M Björkholm, I Turesson… - …, 2016 - haematologica.org
Survival in multiple myeloma (MM) has improved significantly during recent decades both in
younger and older patients. 1, 2 The improved survival is considered to be primarily due to …
younger and older patients. 1, 2 The improved survival is considered to be primarily due to …
[引用][C] Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.
G Jonsdottir, SH Lund, M Björkholm, I Turesson… - …, 2016 - portal.research.lu.se
Survival in multiple myeloma patients who develop second malignancies: a population-based
cohort study. — Lund University Skip to main navigation Skip to search Skip to main content …
cohort study. — Lund University Skip to main navigation Skip to search Skip to main content …
Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study
G Jonsdottir, SH Lund, M Björkholm… - Haematologica …, 2016 - scholarship.miami.edu
Abstract Aged Antineoplastic Agents-therapeutic use Cohort Studies Female Humans
Leukemia, Myeloid, Acute-drug therapy Leukemia, Myeloid, Acute-etiology Leukemia …
Leukemia, Myeloid, Acute-drug therapy Leukemia, Myeloid, Acute-etiology Leukemia …
Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.
G Jonsdottir, SH Lund, M Björkholm, I Turesson… - …, 2015 - europepmc.org
Survival in multiple myeloma (MM) has improved significantly during recent decades both in
younger and older patients. 1, 2 The improved survival is considered to be primarily due to …
younger and older patients. 1, 2 The improved survival is considered to be primarily due to …
[PDF][PDF] Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study
G Jonsdottir, SH Lund, M Björkholm, I Turesson… - 2015 - researchgate.net
Survival in multiple myeloma patients who develop second malignancies: a population-based
cohort study Page 1 Survival in multiple myeloma patients who develop second malignancies …
cohort study Page 1 Survival in multiple myeloma patients who develop second malignancies …
[引用][C] Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.
G Jonsdottir, SH Lund, M Björkholm, I Turesson… - Haematologica, 2016 - lup.lub.lu.se
Survival in multiple myeloma patients who develop second malignancies: a population-based
cohort study. | Lund University Publications Skip to main content LUND UNIVERSITY | LUND …
cohort study. | Lund University Publications Skip to main content LUND UNIVERSITY | LUND …
Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study
G Jonsdottir, SH Lund, M Björkholm… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Survival in multiple myeloma patients who develop second malignancies: a population-based
cohort study Survival in multiple myeloma patients who develop second malignancies: a …
cohort study Survival in multiple myeloma patients who develop second malignancies: a …
[HTML][HTML] Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study
G Jonsdottir, SH Lund, M Björkholm, I Turesson… - …, 2016 - haematologica.org
Survival in multiple myeloma (MM) has improved significantly during recent decades both in
younger and older patients. 2 1 The improved survival is considered to be primarily due to …
younger and older patients. 2 1 The improved survival is considered to be primarily due to …